423 related articles for article (PubMed ID: 19076355)
1. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
van Venrooij WJ; van Beers JJ; Pruijn GJ
Ann N Y Acad Sci; 2008 Nov; 1143():268-85. PubMed ID: 19076355
[TBL] [Abstract][Full Text] [Related]
2. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis.
van Venrooij WJ; Zendman AJ; Pruijn GJ
Autoimmun Rev; 2006 Nov; 6(1):37-41. PubMed ID: 17110315
[TBL] [Abstract][Full Text] [Related]
4. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
5. [A new marker for the diagnosis of rheumatoid arthritis: cyclic citrullinated peptide antibodies (anti-CCP)].
Altindiş M
Mikrobiyol Bul; 2003 Oct; 37(4):313-8. PubMed ID: 14748270
[TBL] [Abstract][Full Text] [Related]
6. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.
Boire G; Cossette P; de Brum-Fernandes AJ; Liang P; Niyonsenga T; Zhou ZJ; Carrier N; Daniel C; Ménard HA
Arthritis Res Ther; 2005; 7(3):R592-603. PubMed ID: 15899046
[TBL] [Abstract][Full Text] [Related]
7. [Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis].
Orbach H; Shoenfeld Y
Harefuah; 2003 Mar; 142(3):182-5, 239. PubMed ID: 12696470
[TBL] [Abstract][Full Text] [Related]
8. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
9. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
10. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
van Venrooij WJ; van de Putte LB
Ned Tijdschr Geneeskd; 2003 Feb; 147(5):191-4. PubMed ID: 12645351
[TBL] [Abstract][Full Text] [Related]
11. [New biomarkers for rheumatoid arthritis].
Hayashi N; Nishimura K; Kumagai S
Rinsho Byori; 2008 Apr; 56(4):297-308. PubMed ID: 18516964
[TBL] [Abstract][Full Text] [Related]
12. [Early prediction of joint destruction in rheumatoid arthritis].
Eguchi K
Clin Calcium; 2007 Apr; 17(4):517-25. PubMed ID: 17404480
[TBL] [Abstract][Full Text] [Related]
13. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
14. Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
Vallbracht I; Helmke K
Autoimmun Rev; 2005 Jul; 4(6):389-94. PubMed ID: 16081030
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
Bas S
Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
[TBL] [Abstract][Full Text] [Related]
16. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis.
Niewold TB; Harrison MJ; Paget SA
QJM; 2007 Apr; 100(4):193-201. PubMed ID: 17434910
[TBL] [Abstract][Full Text] [Related]
17. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S
J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
Lee AN; Beck CE; Hall M
Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
[TBL] [Abstract][Full Text] [Related]
19. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis.
van Oosterhout M; Bajema I; Levarht EW; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2008 Jan; 58(1):53-60. PubMed ID: 18163491
[TBL] [Abstract][Full Text] [Related]
20. [New diagnostic and evaluative tests for rheumatoid arthritis].
Hayashi N; Nishimura K; Morinobu A; Kumagai S
Rinsho Byori; 2007 Apr; 55(4):388-96. PubMed ID: 17511271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]